Viewing Study NCT06683092


Ignite Creation Date: 2025-12-24 @ 3:31 PM
Ignite Modification Date: 2026-02-22 @ 4:52 PM
Study NCT ID: NCT06683092
Status: RECRUITING
Last Update Posted: 2025-11-03
First Post: 2024-11-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)
Sponsor: Boston Children's Hospital
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: IRB-P00050262
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View
None OTHER View